Minneapolis, MN, United States of America

Pedram Afshar

This inventor holds 14 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Medtronic, Inc., Element Science, Inc., Leland Stanford Junior University. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pedram Afshar. Retrieved from https://idiyas.com/inventor/pedram-afshar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 92.9


 

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 91(Granted Patents)


Location History:

  • Minneapolis, MN (US) (2017 - 2022)
  • San Francisco, CA (US) (2018 - 2023)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Pedram Afshar: Innovator from Minneapolis

Introduction: Pedram Afshar is a renowned inventor based in Minneapolis, MN, known for his groundbreaking contributions to various fields.

Latest Patents: Pedram Afshar holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a successful career spanning over two decades, Pedram Afshar has worked on numerous projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout his career, Pedram Afshar has collaborated with leading experts in the field, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Pedram Afshar's dedication to innovation and his passion for creating impactful solutions have solidified his reputation as a visionary inventor in Minneapolis and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…